Biobanking is crucial for advancing medical research and personalized medicine, offering high-quality biospecimens for studies on biomarkers, drug development, and diagnostics. Despite its global potential, challenges such as fragmented governance and varying standards hinder biorepository collaboration, particularly in South Africa (SA). A unified national biobank network could enhance research and healthcare by improving biospecimen access, ethical governance, and collaboration. Global biobank networks offer models for standardization, data sharing, and international cooperation. SA can benefit from these models by creating a centralized biobank platform, promoting capacity building, and fostering regional and global partnerships. To address the challenges SA faces regarding biobanking, the Medical Biobanks Cluster established a network named Medical Biorepositories of SA (MBirSA), which seeks to build a cohesive network of medical biorepositories in SA. Through this network, it plans to foster an inclusive culture of biospecimen and data protocol harmonization, while encouraging adherence to legal, ethical, and quality best practices and standards. The network aims to bring stakeholders together, increasing visibility and transparency, and encouraging sector-wide collaboration. MBirSA also aims to offer training to build capacity in global best practices, aid in the development of dependable biorepository infrastructure, and promote research partnerships to enhance healthcare advancements.
Get full access to this article
View all access options for this article.
References
1.
AbayomiA, ChristoffelsA, GrewalR, et al.Challenges of biobanking in South Africa to facilitate indigenous research in an environment burdened with human immunodeficiency virus, tuberculosis, and emerging noncommunicable diseases. Biopreserv Biobank, 2013; 11(6):347–354.
2.
MalsagovaK, KopylovA, StepanovA, et al.Biobanks—a platform for scientific and biomedical research. Diagnostics, 2020; 10(7):485.
3.
ParkA. 10 Ideas Changing the World Right Now. 2009.
4.
RiegmanPH, MorenteMM, BetsouF, et al.;Marble Arch International Working Group on Biobanking for Biomedical Research. Biobanking for better healthcare. Mol Oncol, 2008; 2(3):213–222.
5.
WoolfSH. The meaning of translational research and why it matters. JAMA, 2008; 299(2):211–213.
6.
CicekMS, OlsonJE. Mini-review of laboratory operations in biobanking: Building biobanking resources for translational research. Front Public Health, 2020; 8:362.
7.
GolubnitschajaO, BabanB, BonioloG, et al.Medicine in the early twenty-first century: Paradigm and anticipation-EPMA position paper 2016. Epma J, 2016; 7(1):23.
8.
GolubnitschajaO, KinkorovaJ, CostigliolaV. Predictive, preventive and personalised medicine as the hardcore of ‘Horizon 2020’: EPMA position paper. Epma J, 2014; 5(1):6–29.
9.
Peiró-ChovaL, PonceOB, Abril-TormoC, et al.The importance of biobanks in epigenetic studies. Epigenetic Biomarkers and Diagnostics, 2016; 19–35.
10.
KinkorováJ, TopolčanO. Biobanks in Horizon 2020: Sustainability and attractive perspectives. Epma J, 2018; 9(4):345–353.
11.
KayeJ, HeeneyC, HawkinsN, et al.Data sharing in genomics—re-shaping scientific practice. Nat Rev Genet, 2009; 10(5):331–335.
12.
SoteloRNG, CentenoJEO, ArzolaLIH, et al.A multidisciplinary approach to the Biobank concept: Integrative review. Cien Saude Colet, 2021; 26(9):4321–4339.
13.
LabuschaigneM, MahomedS. Regulatory challenges relating to tissue banks in South Africa: Impediments to accessing healthcare. South African J Bioethics Law, 2019; 12(1):27–31.
14.
SooCC, MukomanaF, HazelhurstS, et al.Establishing an academic biobank in a resource-challenged environment. South African Medical Journal, 2017; 107(6):486–492.
15.
SinghS, MoodleyK. Stakeholder perspectives on the ethico-legal dimensions of biobanking in South Africa. BMC Med Ethics, 2021; 22(1):84.
16.
AndandaP, GovenderS. Regulation of biobanks in South Africa. J Law Med Ethics, 2015; 43(4):787–800.
17.
GoebelJW, SchellerJ. Do we need a biobank law? Journal of Laboratory Medicine, 2019; 43(6):311–315.
18.
SchneiderJW, SandersonM, GeigerD, et al.A biobank to support HIV malignancy research for sub-Saharan Africa. South African Medical Journal, 2016; 106(9):867–869.
19.
WaldmannA, AnzenederT, KatalinicA. Patients and methods of the PATH Biobank–A resource for breast cancer research. Geburtshilfe Frauenheilkd, 2014; 74(4):361–369.
20.
AbimikuA, MayneES, JolobaM, et al.H3Africa biorepository program: Supporting genomics research on African populations by sharing high-quality biospecimens. Biopreservation and Biobanking, 2017; 15(2):99–102.
21.
ThobelaMS, MasemeMR, DumaBM. An overview of the National Biobank of the national health laboratory service: A South African national treasure for biological resources. Journal of Laboratory Medicine, 2022; 46(2):83–97.
SamuelG, SimsJM. Drivers and constraints to environmental sustainability in UK-based biobanking: Balancing resource efficiency and future value. BMC Med Ethics, 2023; 24(1):36.
24.
HolubP, KozeraL, FlorindiF, et al.;BBMRI-ERIC community. BBMRI-ERIC’s contributions to research and knowledge exchange on COVID-19. Eur J Hum Genet, 2020; 28(6):728–731.
25.
LipworthW, KerridgeI, StewartC, et al.Public trust and global biobank networks. BMC Med Ethics, 2020; 21(1):73.
26.
GiriJ, PezziL, CachayR, et al.Specimen sharing for epidemic preparedness: Building a virtual biorepository system from local governance to global partnerships. PLOS Glob Public Health, 2023; 3(10):e0001568.
27.
MunungNS, MayosiBM, de VriesJ. Equity in international health research collaborations in Africa: Perceptions and expectations of African researchers. PLoS One, 2017; 12(10):e0186237.
28.
ConradieEH, MalherbeH, HendrikszCJ, et al.An overview of benefits and challenges of rare disease biobanking in Africa, focusing on South Africa. Biopreserv Biobank, 2021; 19(2):143–150.
29.
OluOO, KaramagiHC, OkeibunorJC. Harnessing digital health innovations to improve healthcare delivery in Africa: Progress, challenges and future directions. Frontiers Media SA: 2023.
30.
MoodleyK, SinghS. “It’s all about trust”: reflections of researchers on the complexity and controversy surrounding biobanking in South Africa. BMC Med Ethics, 2016; 17(1):57–59.
31.
Council NHRE. South African Ethics in health research guidelines: Principles, processes and structures. In: National Department of Health of the Republic of South Africa Pretoria: NDoH; 2024.
32.
MasemeM, GardnerJ, MahomedS. Broad consent for biobank research in South Africa-Towards an enabling ethico-legal framework. Glob Bioeth, 2024; 35(1):2288331.
33.
PeelingRW, BoerasD, Wilder-SmithA, et al.Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential. Lancet Infect Dis, 2020; 20(10):e268–e273.
34.
OyuchuaM, Siengsanan-LamontJ, LeKK, et al.The importance and challenges of implementing and maintaining biorepositories for High-Consequence veterinary and one health pathogens in South-East Asia. Appl Biosaf, 2024; 29(1):35–44.
35.
KlingströmT, MendyM, MeunierD, et al.Supporting the development of biobanks in low and medium income countries. IEEE; 2016.
36.
RotimiC, AbayomiA, AbimikuA, et al.;H3Africa Consortium. Research capacity. Enabling the genomic revolution in Africa. Science, 2014; 344(6190):1346–1348.
37.
AbayomiA, GevaoS, ContonB, et al.African civil society initiatives to drive a biobanking, biosecurity and infrastructure development agenda in the wake of the West African Ebola outbreak. Pan Afr Med J, 2016; 24:270.
38.
MatimbaA, TybringG, ChiterekaJ, et al.Practical approach to biobanking in Zimbabwe: Establishment of an inclusive stakeholder framework. Biopreserv Biobank, 2016; 14(5):440–446.
39.
KinkorováJ. Education for future biobankers-the state-of-the-art and outlook. Epma J, 2021; 12(1)(:15–25.
40.
AkinyemiRO, AkinwandeK, DialaS, et al.Biobanking in a challenging African environment: Unique experience from the SIREN project. Biopreserv Biobank, 2018; 16(3):217–232.
41.
MendyM, LawlorRT, van KappelAL, et al.Biospecimens and biobanking in global health. Clin Lab Med, 2018; 38(1):183–207.
42.
MeirK, GaffneyEF, Simeon-DubachD, et al.The human face of biobank networks for translational research. Biopreserv Biobank, 2011; 9(3):279–285.
43.
VaughtJ, KellyA, HewittR. A review of international biobanks and networks: Success factors and key benchmarks. Biopreserv Biobank, 2009; 7(3):143–150.
44.
DevereuxL, WatsonPH, Mes-MassonA-M, et al.A review of international biobanks and networks: Success factors and key benchmarks—A 10-year retrospective review. Biopreserv Biobank, 2019; 17(6):512–519.
45.
LeeS, NamS, JungPE, et al.Asian Network of Research Resource Centers. Biopreserv Biobank, 2016; 14(5):424–428.
46.
WitońM, StrapagielD, Gleńska-OlenderJ, et al.Organization of BBMRI. pl: The Polish biobanking network. Biopreserv Biobank, 2017; 15(3):264–269.
